CBLL - יחס חוב להיוון בספרים CeriBell Inc

CeriBell, Inc. (CBLL) is implementing breakthrough AI-powered portable EEG systems for the rapid detection of epileptic seizures. The current strategy relies on the development of a unified diagnostic platform, creating a dependency on the pace of its adoption within clinics. Risks are associated with the slow upgrading of hospital equipment and the need for investment, while the metric stands at 0.18. The financial price visualization below demonstrates the asset's price action.

To select assets with the maximum margin of safety, it is critical to evaluate the share of total liabilities in the overall book value of the business. By analyzing the debt-to-capitalization ratio, an investor determines the default risk amid rising rates, which is particularly significant for CeriBell, Inc. (CBLL) as it scales its innovative AI seizure monitoring system in intensive care units.